Stay updated on Semaglutide Combo vs Higher Insulin Alone in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Combo vs Higher Insulin Alone in Type 2 Diabetes Clinical Trial page.

Latest updates to the Semaglutide Combo vs Higher Insulin Alone in Type 2 Diabetes Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s displayed software/version label has been updated from Revision v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check47 days agoChange DetectedVersion 2026-03-25 introduces QC status and adds multiple sections to the record, including More Information, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and updated Study Status. It also expands the Documents/Document Section area to provide additional references and contacts for the study.SummaryDifference0.8%

- Check54 days agoChange DetectedRevision: v3.5.0 was added to the history. Revision: v3.4.3 was removed from the history.SummaryDifference0.1%

- Check62 days agoChange DetectedThe history now shows 'Results Submitted' replacing 'No Results Posted', and the page revision is updated to v3.4.3.SummaryDifference0.1%

- Check91 days agoChange DetectedThe record history adds Revision: v3.4.2 and removes Revision: v3.4.1. This reflects a minor version update in the history.SummaryDifference0.1%

Stay in the know with updates to Semaglutide Combo vs Higher Insulin Alone in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Combo vs Higher Insulin Alone in Type 2 Diabetes Clinical Trial page.